The Effect of Activated Factor VII for Intracerebral Hemorrhage Beyond 3 Hours Versus Within 3 Hours

BACKGROUND AND PURPOSE: Recombinant-activated factor VII (rFVIIa) is an investigational treatment for intracerebral hemorrhage (ICH). We have evaluated the drug’s treatment effect based on time to treatment. METHODS: ICH patients treated up to 4 hours from symptom onset were divided based on time to...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Hallevi, Hen, Gonzales, Nicole R., Barreto, Andrew D., Martin-Schild, Sheryl, Albright, Karen C., Noser, Elizabeth A., Illoh, Kachi, Khaja, Aslam M., Allison, Teresa, Escobar, Miguel A., Shaltoni, Hashem M., Grotta, James C.
Format: Artigo
Idioma:Inglês
Publicat: 2008
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2677173/
https://ncbi.nlm.nih.gov/pubmed/18174476
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.107.497651
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars